Robert Nordgren

Aptimmune Biologics, Inc. develops and markets a portfolio of revolutionary mucosal vaccines. It focuses on swine vaccines and the prevention of porcine reproductive and respiratory syndrome virus and influenza. The company was founded by Federico Zuckermann in 2010 and is headquartered in Champaign, IL.

Aptimmune Biologics, Inc. develops and markets a portfolio of revolutionary mucosal vaccines. It focuses on swine vaccines and the prevention of porcine reproductive and respiratory syndrome virus and influenza. The company was founded by Federico Zuckermann in 2010 and is headquartered in Champaign, IL.

Covenant Animal Health Partners LLC was founded in 2018 and is based in an undisclosed location. The American company is dedicated to developing and registering "revenue-ready" animal health products to address critical market needs for both production and companion animals. Covenant's experienced team of animal health and technology professionals brings decades of expertise to rapidly evaluate, develop, and partner with animal health manufacturers and distributors. The company also collaborates with industry leaders to fund, develop, and accelerate external innovation initiatives.

Aptimmune Biologics, Inc. develops and markets a portfolio of revolutionary mucosal vaccines. It focuses on swine vaccines and the prevention of porcine reproductive and respiratory syndrome virus and influenza. The company was founded by Federico Zuckermann in 2010 and is headquartered in Champaign, IL.

Covenant Animal Health Partners LLC was founded in 2018 and is based in an undisclosed location. The American company is dedicated to developing and registering "revenue-ready" animal health products to address critical market needs for both production and companion animals. Covenant's experienced team of animal health and technology professionals brings decades of expertise to rapidly evaluate, develop, and partner with animal health manufacturers and distributors. The company also collaborates with industry leaders to fund, develop, and accelerate external innovation initiatives.

Covenant Animal Health Partners LLC was founded in 2018 and is based in an undisclosed location. The American company is dedicated to developing and registering "revenue-ready" animal health products to address critical market needs for both production and companion animals. Covenant's experienced team of animal health and technology professionals brings decades of expertise to rapidly evaluate, develop, and partner with animal health manufacturers and distributors. The company also collaborates with industry leaders to fund, develop, and accelerate external innovation initiatives.